申请人:GLAXO GROUP LTD
公开号:WO2000027832A2
公开(公告)日:2000-05-18
The present invention discloses novel PPARgamma ligands of Formula (I) and pharmaceutically acceptable salts and solvates thereof. The present invention also discloses a method for treating osteoporosis by administration of a PPARgamma antagonist. n=2 - 4 and R1 - R5 are as in the application.